![Zealand announces th](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand announces that Sanofi has submitted LixiLan for regulatory review in the US, triggering a USD 20 million milestone payment
December 23, 2015 01:10 ET
|
Zealand Pharma A/S
The regulatory submission is an important step towards potentially making LixiLan available as a new treatment option for adult Type 2 diabetes patients in the US
Sanofi has redeemed a...
![Zealand to present a](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand to present at 34th Annual J.P. Morgan Healthcare Conference on 14 January 2016
December 18, 2015 09:49 ET
|
Zealand Pharma A/S
Copenhagen, 2015-12-18 15:49 CET (GLOBE NEWSWIRE) --
18 December 2015 – Zealand today announces that the company's CEO Britt Meelby Jensen will present at the 34th Annual J.P. Morgan...
![Zealand præsenterer](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand præsenterer på J.P. Morgans 34. årlige healthcare konference den 14. januar 2016
December 18, 2015 09:49 ET
|
Zealand Pharma A/S
København, 2015-12-18 15:49 CET (GLOBE NEWSWIRE) --
18. december 2015 – Zealand meddeler i dag at selskabets adm. direktør Britt Meelby Jensen vil præsentere på J.P. Morgans årlige healthcare...
![Zealand presented on](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand presented on its dual acting peptides at the New York Academy of Sciences’ meeting GLP-1 Treatment for Diabetes and Beyond
December 09, 2015 03:20 ET
|
Zealand Pharma A/S
Copenhagen, 2015-12-09 09:20 CET (GLOBE NEWSWIRE) --
Acting Senior Vice President of Research Keld Fosgerau presented key examples of Zealand’s novel GLP-1 based dual acting peptides to address...
![Zealand præsenterede](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand præsenterede nogle af sine dobbeltvirkende peptider på New York Academy of Sciences-mødet ”GLP-1-baseret behandling af diabetes og øvrige sygdomme”
December 09, 2015 03:20 ET
|
Zealand Pharma A/S
København, 2015-12-09 09:20 CET (GLOBE NEWSWIRE) --
Fungerende forskningsdirektør Keld Fosgerau præsenterede udvalgte eksempler på Zealands nye GLP-1-baserede, dobbeltvirkende peptider, der...
![Indberetning af lede](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner i Zealands aktier
December 07, 2015 07:40 ET
|
Zealand Pharma A/S
København, 2015-12-07 13:40 CET (GLOBE NEWSWIRE) --
København, 7. december 2015 – I henhold til Værdipapirhandelslovens § 28a skal Zealand indberette transaktioner, der omfatter selskabets aktier og...
![Report of transactio](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Report of transactions in Zealand’s shares and related securities by executives and their related parties
December 07, 2015 07:40 ET
|
Zealand Pharma A/S
Copenhagen, 2015-12-07 13:40 CET (GLOBE NEWSWIRE) --
Copenhagen, 7 December 2015 – Pursuant to the Danish Securities Trading Act, section 28a, Zealand disclose information on transactions with the...
![Zealand increases it](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand increases its share capital as a consequence of exercise of employee warrants
December 04, 2015 08:06 ET
|
Zealand Pharma A/S
Copenhagen, 2015-12-04 14:06 CET (GLOBE NEWSWIRE) --
4 December 2015 – Zealand has increased its share capital with nominal DKK 63,470 divided into 63,470 new shares with a nominal value of DKK 1...
![Zealand forhøjer akt](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
Zealand forhøjer aktiekapitalen som følge af udnyttelsen af medarbejderwarrants
December 04, 2015 08:06 ET
|
Zealand Pharma A/S
København, 2015-12-04 14:06 CET (GLOBE NEWSWIRE) --
4. december 2015 – Zealand meddeler at have forhøjet sin aktiekapital med nominelt 63.470 kr. fordelt på 63.470 nye aktier à nominelt 1 kr....
![CORRECTION: Zealand](/news-release/logo/356649/0/356649.jpg?lastModified=12%2F09%2F2016%2022%3A41%3A25&size=2)
CORRECTION: Zealand annoncerer det samlede antal aktier og stemmerettigheder i selskabet pr. 30. november 2015
December 04, 2015 08:01 ET
|
Zealand Pharma A/S
København, 2015-12-04 14:01 CET (GLOBE NEWSWIRE) --
København, 30. november 2015 – I henhold til § 6 i Bekendtgørelse om udsteders oplysningsforpligtelser meddeler Zealand det samlede antal aktier...